Breast cancer is considered a major health problem in western
countries, and indeed it constitutes the most common cancer among
women in the European Union [48]. A study developed in
by the American Cancer Society estimates that in the United
States between one in eight and one in twelve women will develop
breast cancer during their lifetime [1]. This proportion
is reduced in our country, Catalonia, where it is estimated that
one in sixteen women will develop breast cancer during their
lifetime [58].
In the European Community, breast cancer represents
of
cancer deaths and the
of all cancer cases [47].
Nearly
of all breast cancer deaths occur in women diagnosed
between ages
and
years. In the United States, for
instance, breast cancer remains the leading cause of death for
women in their forties [21].
However, although breast cancer incidence has increased over the past decade, breast cancer mortality has declined among women of all ages [162]. This favourable trend in mortality reduction is considered to be related to the widespread adoption of mammography screening [3,39,71,162,170,176] which allows to detect the cancer at its early stages, and to the improvements made in breast cancer treatment [21].